Drug class
Gastrointestinal prokinetic; dopamine D2 receptor antagonist and acetylcholinesterase inhibitor
Mechanism of action
Combines dopamine D2-receptor antagonism with acetylcholinesterase inhibition. This increases enteric acetylcholine availability and promotes gastrointestinal motility and gastric emptying.
General use cases
- Symptomatic treatment of functional dyspepsia and upper gastrointestinal motility disorders where authorised.
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
